Invention Grant
- Patent Title: Binding molecules specific for FcγRIIA and uses thereof
-
Application No.: US17684018Application Date: 2022-03-01
-
Publication No.: US11746153B2Publication Date: 2023-09-05
- Inventor: Katherine Ann Vousden , Bo Chen , Gary Patrick Sims
- Applicant: VIELA BIO, INC.
- Applicant Address: US IL Deerfield
- Assignee: Viela Bio, Inc.
- Current Assignee: Viela Bio, Inc.
- Current Assignee Address: US IL Deerfield
- Agency: COOLEY LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07K16/28 ; A61P7/00
Abstract:
The disclosure provides FcγRIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting FcγRIIA activity, and methods of using the FcγRIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
Public/Granted literature
- US20220380458A1 BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF Public/Granted day:2022-12-01
Information query
